https://european-biotechnology.net/wp-content/uploads/2025/11/Peter-Hamley-CEO-Scripta-Theraputics-1030x773-1.png7731030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-11-13 00:01:442025-11-13 09:32:03Scripta Therapeutics raises $12m to flip the script on drug discovery
https://european-biotechnology.net/wp-content/uploads/2025/11/Novo-Trump_380460666_eC2ksQPRFWpkTgcwvE5bxK1xc4qVgn7B-e1762502390157.jpg228406Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-11-07 07:59:572025-11-07 07:59:57Eli Lilly and Novo Nordisk slash obesity drug prices
https://european-biotechnology.net/wp-content/uploads/2025/11/AAVantgarde_552298461_-MikeCS-Images-1-1-e1762203895371.jpg233469Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-11-03 21:05:032025-11-03 21:05:03AAVantgarde secures $141m Series B funding
